Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-12

Clinical Trial Update: Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial update examining a simplified maintenance regimen of atazanavir/ritonavir plus lamivudine for HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EVOTAZ (atazanavir and cobicistat)
  • Epivir (Lamivudine)

Snippet

Sponsor: Fundacion SEIMC-GESIDA | Conditions: HIV Infection | Phase 4 | Status: COMPLETED